The Epidemiology and Pathogenesis of Neoplasia in the Small Intestine

Annals of Epidemiology

Volumn 19, Issue 1, 2009, Pages 58-69

  Schottenfeld, David ^a   Beebe Dimmer, Jennifer L ^b,c   Vigneau, Fawn D ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Adenocarcinoma; Bile Acid Metabolism; Cancer Epidemiology; Celiac Disease; Crohn Disease; Gastrointestinal Stromal Tumor; Microbial Flora; Molecular Biology; Neuroendocrine Tumor; Non Hodgkin Lymphoma

Indexed keywords

CYTOKINE;

ADENOMA; ALCOHOL CONSUMPTION; BODY MASS; CANCER INCIDENCE; CANCER RISK; CARCINOID; CARCINOMA; CELL TYPE; CHRONIC INFLAMMATION; COLON ADENOCARCINOMA; COLON CANCER; COLON CARCINOID; COLON SARCOMA; CROHN DISEASE; DEMOGRAPHY; DIET; DUODENUM; ENVIRONMENTAL FACTOR; HUMAN; IMMUNE RESPONSE; JEJUNUM; LARGE INTESTINE; LIFESTYLE; MICROFLORA; MICROORGANISM; MORPHOLOGY; NEUROENDOCRINE TUMOR; NONHODGKIN LYMPHOMA; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMALL INTESTINE; SMALL INTESTINE ADENOCARCINOMA; SMALL INTESTINE CARCINOID; SMALL INTESTINE SARCOMA; SMALL INTESTINE TUMOR; SMOKING;

ADENOCARCINOMA; ADENOMA; COLORECTAL NEOPLASMS; CYTOKINES; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INCIDENCE; INFLAMMATION; INTESTINAL MUCOSA; INTESTINAL NEOPLASMS; INTESTINE, SMALL; LYMPHOMA, NON-HODGKIN; NEUROENDOCRINE TUMORS; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 57049150727     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2008.10.004     Document Type: Review

References (151)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
2. Chow J.S., Chen C.C., Ahsan H., and Neugut A.I. A population-based study of the incidence of malignant small bowel tumors: SEER, 1973-1990. Int J Epidemiol 25 (1996) 722-728
3. Haselkorn T., Whittemore A.S., and Lilienfeld D.E. Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control 16 (2005) 781-787
4. DiSario J.A., Burt R.W., Vargas H., and McWhorter W.P. Small bowel cancer: epidemiological and clinical characteristics from a population-based registry. Am J Gastroenterol 89 (1994) 699-701
5. Neugut A.I., and Santos J. The association between cancers of the small and large bowel. Cancer Epidemiol Biomarkers Prev 2 (1993) 551-553
6. Scelo G., Boffetta P., Hemminki K., Pukkala E., Olsen J.H., Andersen A., et al. Associations between small intestine cancer and other primary cancers: an international population-based study. Int J Cancer 118 (2006) 189-196
7. Curtis RE, Freedman DM, Ron E. New malignancies among cancer survivors: SEER cancer registries, 1973-2000. Bethesda (MD): National Cancer Institute; NIH Publication No. 05-5302, 2006. Ref Type: Generic.
8. Evans H.S., Moller H., Robinson D., Lewis C.M., Bell C.M., and Hodgson S.V. The risk of subsequent primary cancers after colorectal cancer in southeast England. Gut 50 (2002) 647-652
9. Babovic-Vuksanovic D., Constantinou C.L., Rubin J., Rowland C.M., Schaid D.J., and Karnes P.S. Familial occurrence of carcinoid tumors and association with other malignant neoplasms. Cancer Epidemiol Biomarkers Prev 8 (1999) 715-719
10. Chen C.C., Neugut A.I., and Rotterdam H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomarkers Prev 3 (1994) 205-207
11. Tichansky D.S., Cagir B., Borrazzo E., Topham A., Palazzo J., Weaver E.J., et al. Risk of second cancers in patients with colorectal carcinoids. Dis Colon Rectum 45 (2002) 91-97
12. Grossmann J., Walther K., Artinger M., Rummele P., Woenckhaus M., and Scholmerich J. Induction of apoptosis before shedding of human intestinal epithelial cells. Am J Gastroenterol 97 (2002) 1421-1428
13. Playford R.J. Tales from the human crypt-intestinal stem cell repertoire and the origins of human cancer. J Pathol 185 (1998) 119-122
14. Bullen T.F., Forrest S., Campbell F., Dodson A.R., Hershman M.J., Pritchard D.M., et al. Characterization of epithelial cell shedding from human small intestine. Lab Invest 86 (2006) 1052-1063
15. Kloppel G., Perren A., and Heitz P.U. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 1014 (2004) 13-27
16. Modlin I.M., Lye K.D., and Kidd M. Carcinoid tumors of the stomach. Surg Oncol 12 (2003) 153-172
17. Rindi G., Leiter A.B., Kopin A.S., Bordi C., and Solcia E. The "normal" endocrine cell of the gut: changing concepts and new evidences. Ann N Y Acad Sci 1014 (2004) 1-12
18. Modlin I.M., Oberg K., Chung D.C., Jensen R.T., de Herder W.W., Thakker R.V., et al. Gastroenteropancreatic neuroendocrine tumors. Lancet Oncol 9 (2008) 61-72
19. Maggard M.A., O'Connell J.B., and Ko C.Y. Updated population-based review of carcinoid tumors. Ann Surg 240 (2004) 117-122
20. Arnold C.N., Sosnowski A., and Blum H.E. Analysis of molecular pathways in neuroendocrine cancers of the gastroenteropancreatic system. Ann N Y Acad Sci 1014 (2004) 218-219
21. Perren A., Komminoth P., and Heitz P.U. Molecular genetics of gastroenteropancreatic endocrine tumors. Ann N Y Acad Sci 1014 (2004) 199-208
22. Tonnies H., Toliat M.R., Ramel C., Pape U.F., Neitzel H., Berger W., et al. Analysis of sporadic neuroendocrine tumors of the enteropancreatic system by comparative genomic hybridization. Gut 48 (2001) 536-541
23. D'adda T., Pizzi S., Azzoni C., Bottarelli L., Crafa P., Pasquali C., et al. Different patterns of 11q allelic losses in digestive endocrine tumors. Hum Pathol 33 (2002) 322-329
24. Kidd M., Modlin I.M., Pfragner R., Eick G.N., Champaneria M.C., Chan A.K., et al. Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1. Cancer 109 (2007) 2420-2431
25. Kytola S., Hoog A., Nord B., Cedermark B., Frisk T., Larsson C., et al. Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids. Am J Pathol 158 (2001) 1803-1808
26. Das A., Neugut A.I., Cooper G.S., and Chak A. Association of ampullary and colorectal malignancies. Cancer 100 (2004) 524-530
27. Stolte M., and Pscherer C. Adenoma-carcinoma sequence in the papilla of Vater. Scand J Gastroenterol 31 (1996) 376-382
28. Severson R.K., Schenk M., Gurney J.G., Weiss L.K., and Demers R.Y. Increasing incidence of adenocarcinomas and carcinoid tumors of the small intestine in adults. Cancer Epidemiol Biomarkers Prev 5 (1996) 81-84
29. Levine J.S., and Ahnen D.J. Clinical practice. Adenomatous polyps of the colon. N Engl J Med 355 (2006) 2551-2557
30. Sellner F. Investigations on the significance of the adenoma-carcinoma sequence in the small bowel. Cancer 66 (1990) 702-715
31. Campbell W.J., Spence R.A., and Parks T.G. Familial adenomatous polyposis. Br J Surg 81 (1994) 1722-1733
32. Offerhaus G.J., Giardiello F.M., Krush A.J., Booker S.V., Tersmette A.C., Kelley N.C., et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 102 (1992) 1980-1982
33. Jass J.R. Gastrointestinal polyposes: clinical, pathological and molecular features. Gastroenterol Clin North Am 36 (2007) 927-46, viii
34. Arber N., Hibshoosh H., Yasui W., Neuget A.I., Hibshoosh A., Yao Y., et al. Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel. Cancer Epidemiol Biomarkers Prev 8 (1999) 1101-1105
35. Murata M., Iwao K., Miyoshi Y., Nagasawa Y., Yabu M., Himeno S., et al. Activation of the beta-catenin gene by interstitial deletions involving exon 3 as an early event in colorectal tumorigenesis. Cancer Lett 159 (2000) 73-78
36. Rashid A., and Hamilton S.R. Genetic alterations in sporadic and Cohn's-associated adenocarcinomas of the small intestine. Gastroenterology 113 (1997) 127-135
37. Younes N., Fulton N., Tanaka R., Wayne J., Straus F.H., and Kaplan E.L. The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors. Cancer 79 (1997) 1804-1808
38. Zhao B., Kimura W., Futakawa N., Muto T., Kubota K., Harihara Y., et al. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater. Am J Gastroenterol 94 (1999) 2128-2134
39. Fearnhead N.S., Britton M.P., and Bodmer W.F. The ABC of APC. Hum Mol Genet 10 (2001) 721-733
40. Wheeler J.M., Warren B.F., Mortensen N.J., Kim H.C., Biddolph S.C., Elia G., et al. An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut 50 (2002) 218-223
41. Bläker H., von Herbay A., Penzel R., Gross S., and Otto H.F. Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene. Oncogene 21 (2002) 158-164
42. Hamilton S.R., and Arltonen K.A. World Health Organization Classification of tumors: pathology and genetics of tumors of the digestive system (2000), IARC Press, Lyon p. 69-91
43. Lynch H.T., Smyrk T.C., and Lynch P.M. Adenocarcinoma of the small bowel in Lynch syndrome II. Cancer 64 (1989) 2178-2183
44. Mellemkjaer L., Johansen C., Gridley G., Linet M.S., Kjær S.K., and Olsen J. Cohn's disease and cancer risk (Denmark). Cancer Causes Control 11 (2000) 145-150
45. Rodriguez-Bigas M.A., Vasen H.F., Lynch H.T., Watson P., Myrhoj T., Jarvinen H.J., et al. Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC. Cancer 83 (1998) 240-244
46. Schulmann K., Brasch F.E., Kunstmann E., Engel C., Pagenstecher C., Vogelsang H., et al. HNPCC-associated small bowel cancer: clinical and molecular characteristics. Gastroenterology 128 (2005) 590-599
47. Gruber S.B., Entius M.M., Petersen G.M., Laken S.J., Longo P.A., Boyer R., et al. Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res 58 (1998) 5267-5270
48. Jenne D.E., Reimann H., Nezu J., Friedel W., Loff S., Jeschke R., et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18 (1998) 38-43
49. Sato N., Rosty C., Jansen M., Fukushima N., Ueki T., Yeo C.J., et al. STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 159 (2001) 2017-2022
50. Boardman L.A., Thibodeau S.N., Shaid D.J., Lindor N.M., McDonnell S.K., Burgart L.J., et al. Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med 128 (1998) 896-899
51. Giardello F.M., Brensinger J.D., Tersmette A.C., Goodman S.N., Petersen G.M., Booker S.V., et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119 (2000) 1447-1453
52. Konishi F., Wyse N.E., and Muto T. Peutz-Jeghers polyposis associated with carcinoma of the digestive organs. Dis Colon Rectum 30 (1989) 790-799
53. Carbone A. Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol 4 (2003) 22-29
54. Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 5 (2005) 251-262
55. Landgren O., Engels E.A., Pfeiffer R.M., Gridley G., Mellemkjaer L., Olsen J.H., et al. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst 98 (2006) 1321-1330
56. Amieva M.R., and El-Omar E.M. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 134 (2008) 306-323
57. Moslehi R., Devesa S.S., Schairer C., and Fraumeni Jr. J.F. Rapidly increasing incidence of ocular non-Hodgkin lymphoma. J Natl Cancer Inst 98 (2006) 936-939
58. Lecuit M., Abachin E., Martin A., Poyart C., Pochart P., Suarez F., et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 350 (2004) 239-248
59. Zuckerman E., Zuckerman T., Levine A.M., Douer D., Gutekunst K., Mizokami M., et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 127 (1997) 423-428
60. Fine K.D., and Stone M.J. A-heavy chain disease, Mediterranean lymphoma, and immunoproliferative small intestinal disease: a review of clinicopathological features, pathogenesis and differential diagnosis. Am J Gastroenterol 94 (1999) 1139-1152
61. Martin I.G., and Aldoori M.I. Immunoproliferative small intestinal disease: Mediterranean lymphoma and alpha heavy chain disease. Br J Surg 81 (1994) 20-24
62. Anderson L.A., McMillan S.A., Watson R.G., Monaghan P., Gavin A.T., Fox C., et al. Malignancy and mortality in a population-based cohort of patients with coeliac disease or "gluten sensitivity. World J Gastroenterol 13 (2007) 146-151
63. Catassi C., Fabiani E., Corrao G., Barbato M., De Renzo A., Carella A.M., et al. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 287 (2002) 1413-1419
64. Green P.H.R., Fleischauer A.T., Bhagat G., Goyal R., Jabri B., and Neuget A.I. Risk of malignancy in patients with celiac disease. Am J Med (2003) 191-195
65. Peters U., Askling J., Gridley G., Ekbom A., and Linet M. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 163 (2003) 1566-1572
66. Dube C., Rostom A., Sy R., Cranney A., Saloojee N., Garritty C., et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 128 4 Suppl. 1 (2005) S57-S67
67. Rewers M. Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease?. Gastroenterology 128 4 Suppl. 1 (2005) S47-S51
68. Mowat A.M. Coeliac disease-a meeting point for genetics, immunology, and protein chemistry. Lancet 361 (2003) 1290-1292
69. Wolters V.M., and Wijmenga C. Genetic background of celiac disease and its clinical implications. Am J Gastroenterol 103 (2008) 190-195
70. Green P.H., Alaedini A., Sander H.W., Brannagan III T.H., Latov N., and Chin R.L. Mechanisms underlying celiac disease and its neurologic manifestations. Cell Mol Life Sci 62 (2005) 791-799
71. Green P.H.R., and Jabri B. Coeliac disease. Lancet 362 (2003) 383-391
72. Askling J., Linet M., Gridley G., Halstensen T.S., Ekstrom K., and Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 123 (2002) 1428-1435
73. Green P.H., and Jabri B. Celiac disease. Annu Rev Med 57 (2006) 207-221
74. Murray J.A. The widening spectrum of celiac disease. Am J Clin Nutr 69 (1999) 354-365
75. Tran T., Davila J.A., and El-Serag H.B. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol 100 (2005) 162-168
76. Katz S.C., and DeMatteo R.P. Gastrointestinal stromal tumors and leiomyosarcomas. J Surg Oncol 97 (2008) 350-359
77. Rossi C.R., Mocellin S., Mencarelli R., Foletto M., Pilati P., Nitti D., et al. Gastrointestinal stromal tumors: from a surgical to a molecular approach. Int J Cancer 107 (2003) 171-176
78. Corless C.L., and Heinrich M.C. Molecular pathobiology of gastrointestinal stromal sarcomas. Annu Rev Pathol 3 (2008) 557-586
79. Hoeben A., Schöffski P., and Debiec-Rychter M. Clinical implications of mutational analysis in gastrointestinal stromal tumors. Br J Cancer 98 (2008) 684-688
80. Maertens O., Prenen H., Debiec-Rychter M., Wozniak A., Sciot R., Pauwels P., et al. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet 15 (2006) 1015-1023
81. Botteri E., Iodice S., Raimondi S., Maisonneuve P., and Lowenfels A.B. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology 134 (2008) 388-395
82. Terry M.B., and Neugut A.I. Cigarette smoking and the colorectal adenoma-carcinoma sequence: a hypothesis to explain the paradox. Am J Epidemiol 147 (1998) 903-910
83. Kune G.A., and Vitetta L. Alcohol consumption and the etiology of colorectal cancer: a review of the scientific evidence from 1957 to 1991. Nutr Cancer 18 (1992) 97-111
84. Moghaddam A.A., Woodward M., and Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 16 (2007) 2533-2547
85. Pischon T., Lahmann P.H., Boeing H., Friedenreich C., Norat T., Tjonneland A., et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98 (2006) 920-931
86. Ma J., Stampfer M.J., Giovannucci E., Artigas C., Hunter D.J., Fuchs C., et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57 (1997) 1098-1102
87. Michels K.B., Edward G., Joshipura K.J., Rosner B.A., Stampfer M.J., Fuchs C.S., et al. Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst 92 (2000) 1740-1752
88. Trock B., Lanza E., and Greenwald P. Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. J Natl Cancer Inst 82 (1990) 650-661
89. Neugut A.I., Jacobson J.S., Suh S., Mukherjee R., and Arber N. The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev 7 (1998) 243-251
90. Chow W.-H., Linet M.S., and McLaughlin J.K. Risk factors for small intestine cancer. Cancer Causes Control 4 (1993) 163-169
91. Kaerlev L., Teglbjaerg P.S., Sabroe S., Kolstad H.A., Ahrens W., Eriksson M., et al. The importance of smoking and medical history for development of small bowel carcinoid tumor: a European population-based case-control study. Cancer Causes Control 13 (2002) 27-34
92. Kaerlev L., Teglbjaerg P.S., Sabroe S., Kolstad H.A., Ahrens W., Eriksson M., et al. Is there an association between alcohol intake or smoking and small bowel adenocarcinoma? Results from a European multi-center case-control study. Cancer Causes Control 11 (2000) 791-797
93. Wu A.H., Yu M.C., and Mack T.M. Smoking, alcohol use, dietary factors and risk of small intestinal adenocarcinoma. Int J Cancer 70 (1997) 512-517
94. Hassan M.M., Phan A., Li D., Dagohoy C.G., Leary C., and Yao J.C. Risk factors associated with neuroendocrine tumors: a U.S.-based case-control study. Int J Cancer 123 (2008) 867-873
95. Boffetta P., and Hashibe M. Alcohol and cancer. Lancet Oncol 7 (2006) 149-156
96. Seitz H.K., and Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 7 (2007) 599-612
97. Negri E., Bosetti C., La Vecchia C., Fioretti F., Conti E., and Franceschi S. Risk factors for adenocarcinoma of the small intestine. Int J Cancer 82 (1999) 171-174
98. Samanic C., Gridley G., Chow W.H., Lubin J., Hoover R.N., and Fraumeni Jr. J.F. Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 15 (2004) 35-43
99. Wolk A., Gridley G., Svensson M., Nyren O., McLaughlin J.K., Fraumeni Jr. J.F., et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12 (2001) 13-21
100. Bjorge T., Tretli S., and Engeland A. Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. Br J Cancer 93 (2005) 807-810
101. Shanahan F. Cohn's disease. Lancet 359 (2002) 62-69
102. Braun J., and Wei B. Body traffic: ecology, genetics, and immunity in inflammatory bowel disease. Annu Rev Pathol 2 (2007) 401-429
103. Cantor M.J., Nickerson P., and Bernstein C.N. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am J Gastroenterol 100 (2005) 1134-1142
104. Michelassi F., Testa G., Pomidor W.J., Lashner B.A., and Block G.E. Adenocarcinoma complicating Crohn's disease. Dis Colon Rectum 36 (1993) 654-661
105. Ribeiro M.B., Greenstein A.J., Heimann T.M., Yamazaki Y., and Aufses Jr. A.H. Adenocarcinoma of the small intestine in Crohn's disease. Surg Gynecol Obstet 173 (1991) 343-349
106. Jess T., Loftus Jr. E.V., Velayos F.S., Harmsen W.S., Zinsmeister A.R., Smyrk T.C., et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology 130 (2006) 1039-1046
107. Friedman S. Cancer in Crohn's disease. Gastroenterol Clin North Am 35 (2006) 621-639
108. Jess T., Gamborg M., Matzen P., Munkholm P., and Sorensen T.I. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 100 (2005) 2724-2729
109. Eaden J.A., Abrams K.R., and Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48 (2001) 526-535
110. Isolauri E., and Salminen S. Probiotics, gut inflammation and barrier function. Gastroenterol Clin North Am 34 (2005) 437-50, viii
111. Wehkamp J., and Stange E.F. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense. Ann N Y Acad Sci 1072 (2006) 321-331
112. Lievin-Le M.V., and Servin A.L. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev 19 (2006) 315-337
113. Sartor R.B. Microbial influences in inflammatory bowel diseases. Gastroenterology 134 (2008) 577-594
114. Swidsinski A., Ladhoff A., Pernthaler A., Swidsinski S., Loening-Baucke V., Ortner M., et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 122 (2002) 44-54
115. Videla S., Vilaseca J., Guarner F., Salas A., Treserra F., Crespo E., et al. Role of intestinal microflora in chronic inflammation and ulceration of the rat colon. Gut 35 (1994) 1090-1097
116. Bamias G., Nyce M.R., De La Rue S.A., and Cominelli F. New concepts in the pathophysiology of inflammatory bowel disease. Ann Intern Med 143 12 (2005) 895-904
117. Braat H., Peppelenbosch M.P., and Hommes D.W. Immunology of Crohn's disease. Ann NY Acad Sci 1072 (2006) 135-154
118. Schreiber S., Rosenstiel P., Albrecht M., Hampe J., and Krawczak M. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 6 (2005) 376-388
119. Gaya D.R., Russell R.K., Nimmo E.R., and Satsangi J. New genes in inflammatory bowel disease: lessons for complex diseases?. Lancet 367 (2006) 1271-1284
120. Hugot J.P. CARD15/NOD2 mutations in Crohn's disease. Ann N Y Acad Sci 411 (2006) 9-18
121. Ahmad T., Armuzzi A., Bunce M., Mulcahy-Hawes K., Marshall S.E., et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 122 (2002) 854-866
122. Hugot J.P., Chamaillard M., and Zouali H. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
123. Cho J.H., and Abraham C. Inflammatory bowel disease genetics: Nod2. Annu Rev Med 58 (2007) 401-416
124. Lesage S., Zouali H., and Cezard J.P. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70 (2002) 845-857
125. Schottenfeld D., and Beebe-Dimmer J. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 56 (2006) 69-83
126. Smedby K.E., Baecklund E., and Askling J. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev 15 (2006) 2069-2077
127. O'Shea J.J., Ma A., and Lipsky P. Cytokines and autoimmunity. Nat Rev Immunol 2 (2002) 37-45
128. Federico A., Morgillo F., Tuccillo C., Ciardiello F., and Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121 (2007) 2381-2386
129. Guyton A.C., and Hall J.E. Textbook of Medical Physiology. 11th ed. (2006), Elsevier-Saunders, Philadelphia p. 771-817
130. Mazzone A., and Farrugia G. Evolving concepts in the cellular control of gastrointestinal motility: neurogastroenterology and enteric sciences. Gastroenterol Clin North Am 36 (2007) 499-513 vii
131. Guarner F., and Malagelada J.R. Gut flora in health and disease. Lancet 361 (2003) 512-519
132. Lewis S.J., and Heaton K.W. The metabolic consequences of slow colonic transit. Am J Gastroenterol 94 (1999) 2010-2016
133. Mai V., and Morris Jr. J.G. Colonic bacterial flora: changing understandings in the molecular age. J Nutr 134 (2004) 459-464
134. Ouwehand A.C., and Vaughan E.E. Gastrointestinal microbiology (2006), Taylor and Francis, New York
135. Greenstein A.J., Sachar D., Pucillo A., Kreel I., Geller S., Janowitz H.D., et al. Cancer in Crohn's disease after diversionary surgery. A report of seven carcinomas occurring in excluded bowel. Am J Surg 135 (1978) 86-90
136. Bourlioux P., Koletzko B., Guarner F., and Braesco V. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held in Paris, June 14, 2002. Am J Clin Nutr 78 (2003) 675-683
137. Hooper L.V., and Gordon J.I. Glycans as legislators of host-microbial interactions: spanning the spectrum from symbiosis to pathogenicity. Glycobiology 11 (2001) 1R-10R
138. MacDonald T.T., and Gordon J.N. Bacterial regulation of intestinal immune responses. Gastroenterol Clin North Am 34 (2005) 401 viii
139. Laquer G.L. Carcinogenic effects of cycad meal and cycasin, methylazoxymethanol glycoside, in rats and effects of cycasin in germfree rats. Fed Proc 23 (1964) 1386-1387
140. Kim D.H., and Jin Y.H. Intestinal bacterial beta-glucuronidase activity of patients with colon cancer. Arch Pharm Res 24 (2001) 564-567
141. Reddy B.S., and Ohmori T. Effect of intestinal microflora and dietary fat on 3,2'-dimethyl-4-aminobiphenyl-induced colon carcinogenesis in F344 rats. Cancer Res 41 (1981) 1363-1367
142. Reddy B.S., Weisburger J.H., Narisawa T., and Wynder E.L. Colon carcinogenesis in germ-free rats with 1,2-dimethylhydrazine and N-methyl-n'-nitro-N-nitrosoguanidine. Cancer Res 34 (1974) 2368-2372
143. Hofmann A.F. The enterohepatic circulation of bile acids in man. Clin Gastroenterol 6 (1977) 3-24
144. Wexler H.M. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev 20 (2007) 593-621
145. Hill M.J. Bile flow and colon cancer. Mutat Res 238 (1990) 3130-3320
146. Ochsenkuhn T., Bayerdorffer E., Meining A., Schinkel M., Thiede C., Nussler V., et al. Colonic mucosal proliferation is related to serum deoxycholic acid levels. Cancer 85 (1999) 1664-1669
147. Ross R.K., Hartnett N.M., and Bernstein L. Epidemiology of adenocarcinomas of the small intestine: Is bile a small bowel carcinogen?. Br J Cancer 63 (1991) 143-145
148. Imray C.H., Radley S., Davis A., Barker G., Hendrickse C.W., Donovan I.A., et al. Fecal unconjugated bile acids in patients with colorectal cancer or polyps. Gut 33 (1992) 1239-1245
149. Payne C.M., Weber C., Crowley-Skillicorn C., Dvorak K., Bernstein H., Bernstein C., et al. Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells. Carcinogenesis 28 (2007) 215-222
150. Powolny A., Xu J., and Loo G. Deoxycholate induces DNA damage and apoptosis in human colon epithelial cells expressing either mutant or wild-type p53. Int J Biochem Cell Biol 33 (2001) 193-203
151. Lagergren J., Ye W., and Ekbom A. Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis?. Gastroenterology 121 (2001) 542-547